Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 9/2017

01-09-2017 | Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors)

A Scoping Review of Behavioral Economic Interventions for Prevention and Treatment of Type 2 Diabetes Mellitus

Authors: Jeffrey T. Kullgren, Dina Hafez, Allison Fedewa, Michele Heisler

Published in: Current Diabetes Reports | Issue 9/2017

Login to get access

Abstract

Purpose of Review

The purpose of this paper was to review studies of behavioral economic interventions (financial incentives, choice architecture modifications, or commitment devices) to prevent type 2 diabetes mellitus (T2DM) among at-risk patients or improve self-management among patients with T2DM.

Recent Findings

We found 15 studies that used varied study designs and outcomes to test behavioral economic interventions in clinical, workplace, or health plan settings. Of four studies that focused on prevention of T2DM, two found that financial incentives increased weight loss and completion of a fasting blood glucose test, and two choice architecture modifications had mixed effects in encouraging completion of tests to screen for T2DM. Of 11 studies that focused on improving self-management of T2DM, four of six tests of financial incentives demonstrated increased engagement in recommended care processes or improved biometric measures, and three of five tests of choice architecture modifications found improvements in self-management behaviors.

Summary

Though few studies have tested behavioral economic interventions for prevention or treatment of T2DM, those that have suggested such approaches have the potential to improve patient behaviors and such approaches should be tested more broadly.
Literature
1.
Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?: a meta-analysis of prospective studies. Arch Intern Med. 2004;164:2147–55.CrossRefPubMed
2.
Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012;59:635–43.CrossRefPubMed
3.
Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800–11.CrossRefPubMedPubMedCentral
4.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefPubMed
5.
Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374:1677–86.CrossRefPubMedCentral
6.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRefPubMed
7.
Van Gaal L, Scheen A. Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care. 2015;38:1161–72.CrossRefPubMed
8.
Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39:2065–79.CrossRefPubMed
9.
Standards of Medical Care in Diabetes-2017. Summary of revisions. Diabetes Care. 2017;40:S4–5.CrossRef
10.
Pimouguet C, Le Goff M, Thiébaut R, Dartigues JF, Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ. 2011;183:E115–27.CrossRefPubMedPubMedCentral
11.
Vojta D, Sa JD, Prospect T, Stevens S. Effective interventions for stemming the growing crisis of diabetes and prediabetes: a national payer’s perspective. Health Aff. 2012;31:20–6.CrossRef
12.
Vojta D, Koehler TB, Longjohn M, Lever JA, Caputo NF. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program. Am J Prev Med. 2013;44:S301–6.CrossRefPubMed
13.
14.
Yang K, Lee Y-S, Chasens ER. Outcomes of health care providers’ recommendations for healthy lifestyle among U.S. adults with prediabetes. Metab Syndr Relat Disord. 2011;9:231–7.CrossRefPubMed
15.
16.
Ruge T, Nyström L, Lindahl B, Hallmans G, Norberg M, Weinehall L, et al. Recruiting high-risk individuals to a diabetes prevention program: how hard can it be? Diabetes Care. 2007;30:e61.CrossRefPubMed
17.
Gopalan A, Lorincz IS, Wirtalla C, Marcus SC, Long JA. Awareness of prediabetes and engagement in diabetes risk–reducing behaviors. Am J Prev Med. 2015;49:512–9.CrossRefPubMed
18.
Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the U.S., 1988–1994 and 1999–2010. Ann Intern Med. 2014;160:517.CrossRefPubMedPubMedCentral
19.
Wang Y, Bolge SC, Lopez JMS, Zhu VJ, Stang PE. Changes in body weight among people with type 2 diabetes mellitus in the United States, NHANES 2005–2012. Diabetes Educ. 2016;42:336–45.CrossRefPubMed
20.
Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298:2415–7.CrossRefPubMed
21.
O’Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89:103–24.CrossRef
22.
Loewenstein G. Out of control: visceral influences on behavior. Adv. Behav. Econ. Princeton: Princeton University Press; 2004. p. 689–723.
23.
Svenson O. Are we all less risky and more skillful than our fellow drivers? Acta Psychol. 1981;47:143–8.CrossRef
24.
Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47:263–91.CrossRef
25.
Charness G, Gneezy U. Incentives to exercise. Econometrica. 2009;77:909–31.CrossRef
26.
Patel MS, Asch DA, Rosin R, Small DS, Bellamy SL, Heuer J, et al. Framing financial incentives to increase physical activity among overweight and obese adults: a randomized, controlled trial. Ann Intern Med. 2016;164:385–94.CrossRefPubMed
27.
Patel MS, Volpp KG, Rosin R, Bellamy SL, Small DS, Fletcher MA, et al. A randomized trial of social comparison feedback and financial incentives to increase physical activity. Am J Health Promot. 2016;30:416–24.CrossRefPubMed
28.
Patel MS, Asch DA, Rosin R, Small DS, Bellamy SL, Eberbach K, et al. Individual versus team-based financial incentives to increase physical activity: a randomized, controlled trial. J Gen Intern Med. 2016;31:746–54.CrossRefPubMedPubMedCentral
29.
Pope L, Harvey J. The efficacy of incentives to motivate continued fitness-center attendance in college first-year students: a randomized controlled trial. J Am Coll Heal. 2014;62:81–90.CrossRef
30.
Mitchell MS, Goodman JM, Alter DA, John LK, Oh PI, Pakosh MT, et al. Financial incentives for exercise adherence in adults: systematic review and meta-analysis. Am J Prev Med. 2013;45:658–67.CrossRefPubMed
31.
Strohacker K, Galárraga O, Emerson J, Fricchione SR, Lohse M, Williams DM. Impact of small monetary incentives on exercise in university students. Am J Health Behav. 2015;39:779–86.CrossRefPubMed
32.
Royer H, Stehr MF, Sydnor JR. Incentives, commitments and habit formation in exercise: evidence from a field experiment with workers at a Fortune-500 company [internet]. Massachusetts: National Bureau of Economic Research; 2012. Report No.: 18580. Available from: http://​www.​nber.​org/​papers/​w18580 CrossRef
33.
Thorndike AN, Sonnenberg L, Riis J, Barraclough S, Levy DE. A 2-phase labeling and choice architecture intervention to improve healthy food and beverage choices. Am J Public Health. 2012;102:527–33.CrossRefPubMedPubMedCentral
34.
Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive–based approaches for weight loss: a randomized trial. JAMA. 2008;300:2631–7.CrossRefPubMedPubMedCentral
35.
John LK, Loewenstein G, Troxel AB, Norton L, Fassbender JE, Volpp KG. Financial incentives for extended weight loss: a randomized, controlled trial. J Gen Intern Med. 2011;26:621–6.CrossRefPubMedPubMedCentral
36.
Kullgren JT, Troxel AB, Loewenstein G, Norton LA, Gatto D, Tao Y, et al. A randomized controlled trial of employer matching of employees’ monetary contributions to deposit contracts to promote weight loss. Am J Health Promot. 2016;30:441–52.CrossRefPubMed
37.
38.
Jeffery RW, Wing RR, Thorson C, Burton LR, Raether C, Harvey J, et al. Strengthening behavioral interventions for weight loss: a randomized trial of food provision and monetary incentives. J Consult Clin Psychol. 1993;61:1038–45.CrossRefPubMed
39.
Jeffery RW, Gerber WM, Rosenthal BS, Lindquist RA. Monetary contracts in weight control: effectiveness of group and individual contracts of varying size. J Consult Clin Psychol. 1983;51:242–8.CrossRefPubMed
40.
Jeffery RW, Bjornson-Benson WM, Rosenthal BS, Kurth CL, Dunn MM. Effectiveness of monetary contracts with two repayment schedules on weight reduction in men and women from self-referred and population samples. Behav Ther. 1984;15:273–9.CrossRef
41.
Kullgren JT, Troxel AB, Loewenstein G, Asch DA, Norton LA, Wesby L, et al. Individual-versus group-based financial incentives for weight loss: a randomized, controlled trial. Ann Intern Med. 2013;158:505–14.CrossRefPubMedPubMedCentral
42.
Leahey TM, Subak LL, Fava J, Schembri M, Thomas G, Xu X, et al. Benefits of adding small financial incentives or optional group meetings to a web-based statewide obesity initiative. Obesity. 2015;23:70.CrossRefPubMed
43.
44.
Finkelstein EA, Linnan LA, Tate DF, Birken BE. A pilot study testing the effect of different levels of financial incentives on weight loss among overweight employees. J Occup Environ Med. 2007;49:981–9.CrossRefPubMed
45.
Cawley J, Price JA. A case study of a workplace wellness program that offers financial incentives for weight loss. J Health Econ. 2013;32:794–803.CrossRefPubMed
46.
Lahiri S, Faghri PD. Cost-effectiveness of a workplace-based incentivized weight loss program. J Occup Environ Med. 2012;54:371–7.CrossRefPubMed
47.
Volpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272.CrossRefPubMedPubMedCentral
48.
Kimmel SE, Troxel AB, Loewenstein G, Brensinger CM, Jaskowiak J, Doshi JA, et al. Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J. 2012;164:268–74.CrossRefPubMedPubMedCentral
49.
Reese PP, Kessler JB, Doshi JA, Friedman J, Mussell AS, Carney C, et al. Two randomized controlled pilot trials of social forces to improve statin adherence among patients with diabetes. J Gen Intern Med. 2016;31:402–10.CrossRefPubMed
50.
Downs JS, Loewenstein G, Wisdom J. Strategies for promoting healthier food choices. Am Econ Rev. 2009;99:159–64.CrossRef
51.
Liu PJ, Wisdom J, Roberto CA, Liu LJ, Ubel PA. Using behavioral economics to design more effective food policies to address obesity. Appl Econ Perspect Policy. 2014;36:6–24.CrossRef
52.
Keller PA, Harlam B, Loewenstein G, Volpp KG. Enhanced active choice: a new method to motivate behavior change. J Consum Psychol. 2011;21:376–83.CrossRef
53.
Ariely D, Wertenbroch K. Procrastination, deadlines, and performance: self-control by precommitment. Psychol Sci. 2002;13:219–24.CrossRefPubMed
54.
Giné X, Karlan D, Zinman J. Put your money where your butt is: a commitment contract for smoking cessation. Am Econ J Appl Econ. 2010;2:213–35.CrossRef
55.
56.
Rogers T, Milkman KL, Volpp KG. Commitment devices: using initiatives to change behavior. JAMA. 2014;311:2065–6.CrossRefPubMed
57.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.CrossRef
58.
Lorincz IS, Lawson BCT, Long JA. Provider and patient directed financial incentives to improve care and outcomes for patients with diabetes. Curr Diab Rep. 2013;13:188–95.CrossRefPubMedPubMedCentral
59.
Paul-Ebhohimhen V, Avenell A. Systematic review of the use of financial incentives in treatments for obesity and overweight. Obes Rev. 2008;9:355–67.CrossRefPubMed
60.
• Faghri PD, Li R. Effectiveness of financial incentives in a worksite diabetes prevention program. Open Obes J. 2014;6:1–12. This study tested financial incentives for weight loss among employees at high risk for developing T2DM CrossRefPubMedPubMedCentral
61.
Mehrotra A, An R, Patel DN, Sturm R. Impact of a patient incentive program on receipt of preventive care. Am J Manag Care. 2014;20:494–501.PubMedPubMedCentral
62.
Park P, Simmons RK, Prevost AT, Griffin SJ. A randomized evaluation of loss and gain frames in an invitation to screening for type 2 diabetes: effects on attendance, anxiety and self-rated health. J Health Psychol. 2010;15:196–204.CrossRefPubMed
63.
• Sallis A, Bunten A, Bonus A, James A, Chadborn T, Berry D. The effectiveness of an enhanced invitation letter on uptake of National Health Service Health Checks in primary care: a pragmatic quasi-randomised controlled trial. BMC Fam Pract. 2016 [cited 2017 Feb 13];17. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pmc/​articles/​PMC4806508/​. This study tested whether an enhanced invitation letter using insights from behavioral science could increase attendance at National Health Service Health Checks in the UK.
64.
Austin S, Wolfe B. The effect of patient reminders and gas station gift cards on patient adherence to testing guidelines for diabetes. Wis Med J. 2011;110:132–7.
65.
• Gopalan A, Paramanund J, Shaw PA, Patel D, Friedman J, Brophy C, et al. Randomised controlled trial of alternative messages to increase enrolment in a healthy food programme among individuals with diabetes. BMJ Open. 2016;6:e012009. This study compared the effectiveness of T2DM-focused messaging strategies at increasing enrollment in a healthy food program among adults with T2DM CrossRefPubMedPubMedCentral
66.
• Gopalan A, Tahirovic E, Moss H, Troxel AB, Zhu J, Loewenstein G, et al. Translating the hemoglobin A1C with more easily understood feedback: a randomized controlled trial. J Gen Intern Med. 2014;29:996–1003. This study tested the effect of two alternative communication formats of HbA1c values on improving glycemic control among patients with poorly controlled T2DM CrossRefPubMedPubMedCentral
67.
Grady JL, Entin EB, Entin EE, Brunyé TT. Using message framing to achieve long-term behavioral changes in persons with diabetes. Appl Nurs Res. 2011;24:22–8.CrossRefPubMed
68.
• Hochberg I, Feraru G, Kozdoba M, Mannor S, Tennenholtz M, Yom-Tov E. Encouraging physical activity in patients with diabetes through automatic personalized feedback via reinforcement learning improves glycemic control. Diabetes Care. 2016;39:e59–60. This study examined whether a mobile phone application with a learning algorithm could improve adherence to exercise in patients with T2DM CrossRefPubMed
69.
Huntsman MAH, Olivares FJ, Tran CP, Billimek J, Hui EE. Pain reduction and financial incentives to improve glucose monitoring adherence in a community health center. PLoS One. 2014;9:e114875.CrossRefPubMedPubMedCentral
70.
Long JA, Jahnle EC, Richardson DM, Loewenstein G, Volpp KG. Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized controlled trial. Ann Intern Med. 2012;156:416–24.CrossRefPubMedPubMedCentral
71.
• Misra-Hebert AD, Hu B, Taksler G, Zimmerman R, Rothberg MB. Financial incentives and diabetes disease control in employees: a retrospective cohort analysis. J Gen Intern Med. 2016;31:871–7. This study examined whether financial incentives could increase participation in disease management and improve measures of disease control among employees with T2DM CrossRefPubMedPubMedCentral
72.
73.
Raiff BR, Jarvis BP, Dallery J. Text-message reminders plus incentives increase adherence to antidiabetic medication in adults with type 2 diabetes. J Appl Behav Anal. 2016;49:947–53.CrossRefPubMedPubMedCentral
74.
• Sen AP, Sewell TB, Riley EB, Stearman B, Bellamy SL, Hu MF, et al. Financial incentives for home-based health monitoring: a randomized controlled trial. J Gen Intern Med. 2014;29:770–7. This study tested whether financial incentives could increase adherence to home self-monitoring of blood glucose, blood pressure, and weight among patients with poorly controlled T2DM CrossRefPubMedPubMedCentral
75.
76.
Claxton G, Rae M, Long M, Damico A, Whitmore H, Foster G. Health benefits in 2016: family premiums rose modestly, and offer rates remained stable. Health Aff. 2016;35:1908–17.CrossRef
77.
Group TDPPR. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35:723–30.CrossRef
78.
Deci EL, Ryan RM. The “what” and “why” of goal pursuits: human needs and the self-determination of behavior. Psychol Inq. 2000;11:227–68.CrossRef
79.
Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55:68–78.CrossRefPubMed
80.
Kullgren JT, Williams GC, An LC. Patient-centered financial incentives for health: can employers get change for their dollars? Healthcare. 2013;1:82–5.CrossRefPubMed
81.
Kullgren JT, Williams GC, Resnicow K, An LC, Rothberg A, Volpp KG, et al. The promise of tailoring incentives for healthy behaviors. Int J Workplace Health Manag. 2016;9:2–16.CrossRef
82.
Thaler RH. Toward a positive theory of consumer choice. J Econ Behav Organ. 1980;1:39–60.CrossRef
83.
Strotz RH. Myopia and inconsistency in dynamic utility maximization. Rev Econ Stud. 1955;23:165–80.CrossRef
84.
Halpern SD, French B, Small DS, Saulsgiver K, Harhay MO, Audrain-McGovern J, et al. Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med. 2015;372:2108–17.CrossRefPubMedPubMedCentral
Metadata
Title
A Scoping Review of Behavioral Economic Interventions for Prevention and Treatment of Type 2 Diabetes Mellitus
Authors
Jeffrey T. Kullgren
Dina Hafez
Allison Fedewa
Michele Heisler
Publication date
01-09-2017
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 9/2017
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0894-z

Other articles of this Issue 9/2017

Current Diabetes Reports 9/2017 Go to the issue

Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)

Process-Based Treatment of Diabetes in Kaiser Permanente Southern California: How to Make Diabetes Care “Complete”

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?

Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting

Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors)

Academic and Government Partnerships to Address Diabetes in the USA: a Narrative Review

Genetics (AP Morris, Section Editor)

Prioritising Causal Genes at Type 2 Diabetes Risk Loci

Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors)

Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits